← All Staar Surgical CO filings

Staar Surgical CO 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
STAA
Staar Surgical CO
10-K: STAAR Surgical Reports Significant Losses Amid China Slowdown
STAAR Surgical reported a substantial net loss and revenue decline in fiscal 2025, primarily driven by macroeconomic challenges and weak consumer demand in China, alongside costs from a terminated merger and leadership changes.
NASDAQ
STAA
Staar Surgical CO
10-K: STAAR Surgical Reports Fiscal Year 2024 Results Amidst China Market Challenges
STAAR Surgical's fiscal year 2024 saw a revenue decrease and net loss, primarily due to a significant decline in ICL sales in China, impacting overall financial performance.
NASDAQ
STAA
Staar Surgical CO
10-K: STAAR Surgical Amends Lease, Expands Facility and Outlines Executive Compensation
STAAR Surgical Company has amended its lease agreement, expanded its facilities, and detailed executive compensation plans in recent filings.